SynthesisProstate cancer and prostatic diseases2011
Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies.
Synthesis in Prostate cancer and prostatic diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 5 syntheses or guidelines pooled it, 81 citations in OpenAlex.
- Effect of yoga as a complementary therapy in prostate cancer survivors: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Pooled it
- Prevalence and predictors of traditional medicine use among persons with diabetes in Africa: a systematic review.International health · 2024Pooled it
- Potential factors that influence usage of complementary and alternative medicine worldwide: a systematic review.BMC complementary medicine and therapies · 2020Pooled it
- Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review.Integrative cancer therapies · 2017Pooled it
- Phytotherapeutic interventions in the management of biochemically recurrent prostate cancer: a systematic review of randomised trials.BJU international · 2016Pooled it
- A Placebo-Controlled Double-Blinded Randomized Pilot Study of Combination Phytotherapy in Biochemically Recurrent Prostate Cancer.The Prostate · 2017Trial
- A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer.Prostate cancer and prostatic diseases · 2015Trial
- A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy.Cancer prevention research (Philadelphia, Pa.) · 2013Trial
- Trends in the Use of Complementary and Alternative Therapies among US Adults with Current Asthma.Epidemiologia (Basel, Switzerland) · 2023Article
- Use of Complementary and Alternative Medicine for Prostate Cancer among African Americans, African Immigrants and Caribbean Immigrants.Journal of community health · 2022Article
- Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.Evidence-based complementary and alternative medicine : eCAM · 2021Review
- A phytosterol-enriched saw palmetto supercritical COBMC complementary and alternative medicine · 2019Article
- Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer.The Journal of urology · 2019Article
- Effects of Black Raspberries and Their Ellagic Acid and Anthocyanin Constituents on Taxane Chemotherapy of Castration-Resistant Prostate Cancer Cells.Scientific reports · 2019Article
- The Impact of the Socio-Demographic Characteristics of Complementary and Alternative Medicine Users in Serbia on OTC Drug Consumption.Frontiers in public health · 2019Article
- Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors.PloS one · 2018Article
- Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: a single-arm phase II trial.Translational andrology and urology · 2017Article
- A critical review of manual therapy use for headache disorders: prevalence, profiles, motivations, communication and self-reported effectiveness.BMC neurology · 2017Review
- A critical review of complementary and alternative medicine use among people with arthritis: a focus upon prevalence, cost, user profiles, motivation, decision-making, perceived benefits and communication.Rheumatology international · 2017Review
- Use of complementary and alternative medicine before and after organ removal due to urologic cancer.Patient preference and adherence · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
Abstract
Men with prostate cancer are reported as commonly using complementary and alternative medicine (CAM) but surveys have not recently been subjected to a rigorous systematic review incorporating quality assessment. Six electronic databases were searched using pre-defined terms. Detailed information was extracted systematically from each relevant article. Study reporting quality was assessed using a quality assessment tool, which demonstrated acceptable inter-rater reliability and produces a percentage score. In all, 42 studies are reviewed. All were published in English between 1999 and 2009; 60% were conducted in the United States. The reporting quality was mixed (median score = 66%, range 23-94%). Significant heterogeneity precluded formal meta-analysis. In all, 39 studies covering 11,736 men reported overall prevalence of CAM use; this ranged from 8 to 90% (median=30%). In all, 10 studies reported prevalence of CAM use specifically for cancer care; this ranged from 8 to 50% (median = 30%). Some evidence suggested CAM use is more common in men with higher education/incomes and more severe disease. The prevalence of CAM use among men with prostate cancer varies greatly across studies. Future studies should use standardised and validated data collection techniques to reduce bias and enhance comparability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.